홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
SPRO
#3193
Spero Therapeutics, Inc. Common Stock
2.1
7
-0.46%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-0.46%
월간 변동
-8.05%
6달 변화
+10.15%
년간 변동율
+178.21%
이전 종가
2.1
8
Open
2.1
7
Bid
Ask
Low
2.1
7
High
2.1
7
양
8
마켓
주식
헬스케어
SPRO
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
뉴스
Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO)
Spero Therapeutics: COO veräußert Aktien im Wert von 44.000 US-Dollar
Keutzer, Spero Therapeutics COO, sells $44k in shares
Insider-Verkauf bei Spero Therapeutics: CEO veräußert Aktien im Wert von 207.000 US-Dollar
Spero Therapeutics CEO sells $207k in stock
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook
Spero Therapeutics announces board resignation and SEC investigation closure
GSK files NDA resubmission for Spero’s tebipenem HBr antibiotic
Spero Therapeutics: EPS übertrifft Schätzungen um 0,26 $ - Umsatz schlechter als erwartet
Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates
Spero Therapeutics: CEO verkauft Aktien nach starkem Kursanstieg
Spero therapeutics CEO Rajavelu sells $95k in stock